Employer profile
Pendulum Therapeutics
1 certified H-1B filings across 1 fiscal year.
FY2026 filings
1
FY2026 median
$147k
Top role
Staff Process Engineer
1 filings
Top state
CA
1 filings
Pendulum Therapeutics has filed 1 certified H-1B Labor Condition Applications over FY2026. In FY2026, its median certified base salary was $147k ($147k–$147k interquartile range). The most-filed role is Staff Process Engineer (1 filings).
Year-over-year
How Pendulum Therapeutics hired across H-1B fiscal years. YoY column compares to the prior FY.
| FY | Filings | Median $ | YoY % |
|---|---|---|---|
| FY2026 | 1 | $147k | — |
Top job titles
Most-filed positions, across all years (raw DOL titles).
| Job Title | Filings | Median |
|---|---|---|
| Staff Process Engineer | 1 | $147k |
Top worksite states
Where this employer files.
| State | Filings | Median |
|---|---|---|
| CA | 1 | $147k |
Prevailing wage level distribution
DOL Levels I–IV approximate experience tiers (I = entry, IV = fully competent). A heavy Level I/II skew suggests entry-level / contractor-style hiring; a heavy IV skew suggests senior in-house roles.
Lvl III
1100%
Frequently asked questions
- Does Pendulum Therapeutics sponsor H-1B visas?
- Yes. Pendulum Therapeutics has filed 1 certified H-1B Labor Condition Applications (LCAs) over FY2026. An LCA is a required step before an employer files an H-1B petition; a certified LCA does not by itself guarantee an approved visa.
- What is the median H-1B salary at Pendulum Therapeutics?
- In FY2026, the median certified H-1B base salary at Pendulum Therapeutics was $147k, with a 25th–75th percentile range of $147k–$147k. This is the annual base wage stated on the LCA and excludes bonus, equity, and other compensation.
- What jobs does Pendulum Therapeutics hire H-1B workers for?
- Pendulum Therapeutics's most-filed H-1B role is Staff Process Engineer (1 filings). Its top worksite state is CA.
- How many H-1B filings did Pendulum Therapeutics submit in FY2026?
- Pendulum Therapeutics had 1 certified H-1B LCA filings in FY2026.